Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer

被引:0
|
作者
Thongprasert, Sumitra [1 ]
Boldeanu, Cosmin [2 ]
Radosavljevic, Davorin [3 ]
Petrovic, Marina [4 ]
Jones, Hilary [5 ]
Cseh, Agnieszka [6 ]
Gaafar, Rabab [7 ]
机构
[1] Chiang Mai Univ, Fac Med, Dept Med, Chiang Mai 50000, Thailand
[2] Braila Cty Emergency Hosp, Braila, Romania
[3] Inst Oncol & Radiol Serbia, Belgrade, Serbia
[4] Clin Ctr Kragujevac, Kragujevac, Serbia
[5] Boehringer Ingelheim Ltd, Dept Oncol, Bracknell, Berks, England
[6] Boehringer Ingelheim Rcv Gmbh & Co Kg, Dept Oncol, Vienna, Austria
[7] Cairo Univ, Natl Canc Inst, Cairo, Egypt
关键词
afatinib; NSCLC; EGFR mutated; Second-line;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P3.01-088
引用
收藏
页码:S667 / S667
页数:1
相关论文
共 50 条
  • [21] Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer
    Greenhalgh, J.
    McLeod, C.
    Bagust, A.
    Boland, A.
    Fleeman, N.
    Dundar, Y.
    Oyee, J.
    Dickson, R.
    Davis, H.
    Green, J.
    McKenna, E.
    Pearson, M.
    HEALTH TECHNOLOGY ASSESSMENT, 2010, 14 : 33 - 39
  • [22] Salvage surgery in patients with locally advanced or metastatic non-small cell lung cancer
    Werner, R. S.
    Furrer, K.
    Lauk, O.
    Caviezel, C.
    Hillinger, S.
    Schneiter, D.
    Britschgi, C.
    Guckenberger, M.
    Opitz, I.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) : S106 - S107
  • [23] Salvage Surgery in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer
    Werner, R. S.
    Furrer, K.
    Lauk, O.
    Caviezel, C.
    Hillinger, S.
    Schneiter, D.
    Britschgi, C.
    Guckenberger, M.
    Opitz, I
    BRITISH JOURNAL OF SURGERY, 2023, 110 (SUPP 5)
  • [24] Phase 1 study of olaparib as radiosensitizer for locally advanced non-small cell lung cancer
    De Haan, R.
    Van Diessen, J.
    Peulen, H. M. U.
    Van Werkhoven, E.
    De langen, A. J.
    Lalezari, F.
    Vens, C.
    Schellens, J.
    Steeghs, N.
    Van den Heuvel, M. M.
    Verheij, M.
    Van Triest, B.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S386 - S387
  • [25] Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer
    Atmaca, Akin
    Al-Batran, Salah-Eddin
    Allgaeuer, Michael
    Jaeger, Elke
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 (05) : 262 - +
  • [26] Preliminary results of a phase II study with weekly docetaxel as second line chemotherapy in locally advanced (IIIB) and metastatic (IV) non-small cell lung cancer
    Rossil, D
    Graziano, F
    Alessandroni, P
    Fedeli, SL
    Fedeli, A
    Catalano, V
    Giordani, JP
    Baldelli, AM
    Catalano, G
    ANNALS OF ONCOLOGY, 2000, 11 : 10 - 10
  • [27] Surgery in locally advanced non-small cell lung cancer
    Naruke, T
    LUNG CANCER, 2003, 42 : S11 - S15
  • [28] Locally Advanced, Unresectable Non-Small Cell Lung Cancer
    Sonam Puri
    Andreas Saltos
    Bradford Perez
    Xiuning Le
    Jhanelle E. Gray
    Current Oncology Reports, 2020, 22
  • [29] Chemoradiation for locally advanced non-small cell lung cancer
    Girard, N.
    Mornex, F.
    CANCER RADIOTHERAPIE, 2007, 11 (1-2): : 67 - 76
  • [30] Treatment of Locally Advanced Non-Small Cell Lung Cancer
    Tam, Kit
    Daly, Megan
    Kelly, Karen
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 45 - +